Stay updated on Nivolumab and Cyclophosphamide for R/R AML Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added a Locations section listing Minnesota as the study site, and removed the Minnesota Locations entry and the HHS Vulnerability Disclosure link. The page revision was updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-21T23:26:47.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Footer revision indicator updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-30T10:12:32.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Footer revision updated from v3.2.0 to v3.3.1. There are no changes to study details or page content.
    Difference
    0.1%
    Check dated 2025-11-23T07:56:42.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice about NIH operations and site status on this trial page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-16T05:52:04.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected; the page content and structure remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-02T00:12:04.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    Upgraded to version v3.2.0 with a funding-status notice about operational limitations; v3.1.0 was removed. Indicates a maintenance/availability update rather than new content.
    Difference
    4%
    Check dated 2025-10-04T03:08:26.000Z thumbnail image

Stay in the know with updates to Nivolumab and Cyclophosphamide for R/R AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Cyclophosphamide for R/R AML Clinical Trial page.